WILLIAM C. KIMBALL - Corporate Board Profile

CASEYS GENERAL STORES INC

Filing Date	Source Excerpt
2011-08-05	William C. Kimball, 63, retired Chairman and Chief Executive Officer of Medicap Pharmacy, Inc., a national franchisor of community retail pharmacies, and currently a partner in Kimball-Porter Investments, LLC, an Iowa-based investment company. Mr. Kimball also serves as a member of the Board of Directors of Principal Mutual Funds. The Executive Committee presently consists of Mr. Myers, Mr. Haynie, Mr. Kimball and Mr. Wilkey. The Compensation Committee presently consists of Mr. Haynie (Chair), Mr. Kimball, Mr. Wilkey and Mr. Horak, all of whom are “independent” under the Nasdaq Listing Standards. The Nominating and Corporate Governance Committee presently consists of Mr. Lamberti (Chair), Mr. Danos, Mr. Kimball and Mr. Wilkey, all of whom are “independent” under the Nasdaq Listing Standards. During the 2011 fiscal year, each director who was not a Company employee was compensated for services as a director by an annual retainer of $40,000. Mr. Kimball was compensated $62,000 in fees earned or paid in cash and $71,880 in stock awards, totaling $133,988.
2012-08-03	Mr. Kimball has been a director of the Company since 2004, and currently serves as the Lead Director of the Board. The Executive Committee presently consists of Mr. Myers, Mr. Haynie, Mr. Kimball and Mr. Wilkey. The Compensation Committee presently consists of Mr. Haynie (Chair), Mr. Kimball, Mr. Wilkey and Mr. Horak. The Nominating and Corporate Governance Committee presently consists of Mr. Lamberti (Chair), Mr. Danos, Mr. Kimball and Mr. Wilkey. In December 2008, the Board of Directors established a Succession Planning Committee, with Mr. Danos serving as its Chair, to regularly review succession planning for the Chief Executive Officer and other executive officer positions. Other members of the Succession Planning Committee include Messrs. Kimball, Lamberti, Wilkey and Horak. The following table sets out the compensation paid to or on behalf of our directors during the 2012 fiscal year: William C. Kimball: $127,458.
2013-08-02	William C. Kimball, 65, retired Chairman and Chief Executive Officer of Medicap Pharmacy, Inc... He has been a director of the Company since 2004, and currently serves as the Lead Director of the Board... The Executive Committee presently consists of Mr. Myers, Mr. Haynie, Mr. Kimball and Mr. Wilkey... The Compensation Committee presently consists of Mr. Haynie (Chair), Mr. Kimball, Mr. Wilkey and Mr. Horak... The Nominating and Corporate Governance Committee presently consists of Mr. Lamberti (Chair), Mr. Danos, Mr. Kimball and Mr. Wilkey... The Succession Planning Committee includes Messrs. Kimball, Lamberti, Wilkey and Horak... The following table sets out the compensation paid to or on behalf of our directors during the 2013 fiscal year: William C. Kimball: $160,250.
2014-08-08	William C. Kimball, 66, retired Chairman and Chief Executive Officer of Medicap Pharmacy, Inc., a national franchisor of community retail pharmacies, and currently a partner in Kimball-Porter Investments, LLC, an Iowa-based investment company. Mr. Kimball also serves as a member of the Board of Directors of Principal Mutual Funds. Mr. Kimball has been a director of the Company since 2004, and currently serves as the Lead Director of the Board (described on page 7).
2015-08-07	Mr. Kimball has been a director of the Company since 2004, and currently serves as the Lead Director of the Board. The Executive Committee presently consists of Mr. Myers (Chair), Mr. Haynie, Mr. Kimball and Mr. Lamberti. The Compensation Committee presently consists of Mr. Horak (Chair), Mr. Kimball, Mr. Wilkey and Mr. Haynie. The Nominating and Corporate Governance Committee presently consists of Mr. Wilkey (Chair), Mr. Danos, Mr. Kimball and Ms. Renda. During the 2015 fiscal year, each director who was not a Company employee was compensated for services as a director in the amount of $180,000, with equity in the form of restricted stock comprising not less than $100,000 of that amount. The Lead Director, Mr. Kimball, also received an annual retainer of $16,000 for his services as such. The following table sets out the compensation paid to or on behalf of our directors during the 2015 fiscal year: William C. Kimball: $350,110.
2016-08-05	William C. Kimball, 68, retired Chairman and Chief Executive Officer of Medicap Pharmacy, Inc... Mr. Kimball has been a director of the Company since 2004, and currently serves as the Lead Director of the Board... The Executive Committee presently consists of Mr. Myers (Chair), Mr. Handley, Mr. Kimball and Mr. Lamberti... The Compensation Committee presently consists of Mr. Horak (Chair), Mr. Kimball, and Ms. Renda... The Nominating and Corporate Governance Committee presently consists of Mr. Wilkey (Chair), Mr. Danos, and Mr. Kimball... In December 2008, the Board of Directors established a Succession Planning Committee, with Mr. Danos serving as its Chair, to regularly review succession planning... During the 2016 fiscal year, each director who was not a Company employee was compensated for services as a director in the amount of $180,000... William C. Kimball received total compensation of $209,070.
2017-08-04	William C. Kimball, 69, retired Chairman and Chief Executive Officer of Medicap Pharmacy, Inc. Mr. Kimball has been a director of the Company since 2004, and currently serves as the Lead Director of the Board. The Executive Committee presently consists of Mr. Myers (Chair), Mr. Handley, Mr. Kimball and Mr. Lamberti. The Compensation Committee presently consists of Mr. Horak (Chair), Mr. Kimball, and Ms. Renda. The Nominating and Corporate Governance Committee presently consists of Mr. Kimball (acting Chair) and Mr. Danos. The Succession Planning Committee includes Messrs. Kimball, Lamberti, and Horak.